​Dioscorea Hispida (Intoxicating Yam / Asiatic Bitter Yam)

Dioscorea Hispida (Intoxicating Yam / Asiatic Bitter Yam)

Product Name: Диоскорея шероховатая, Dioscorea hispida, Rauhhaar-Yamswurzel, Ñame áspero, Igname hispide, اليام الخشن, มันทรงกระเทียม, Yovvoyi jams, Жабагай ямс, Kobud yams, Ямс хирсютус, Plaukuotoji dioskorėja, Skujkārtainā dioskorėja, Діоскорея шорстка, Kobud yams, דיוסקוריה שעירה

Synonyms: Диоскорея шершавая, Шершавый ямс, Dioscorea hispida Dennst., Dioscorea daemona, Dioscorea sumatrana, Dioscorea macrophylla var. hispida, Intoxicating Yam, Asiatic Bitter Yam, wild yam, rough yam, igname rugueux, yam sauvage rugueux, ñame áspero, ñame venenoso, اليام البري الخشن, มันทรงกระเทียม.

Parts used: rhizomes, tubers, leaves, seeds, shoots, stems, flowers.

Main indications for the use of Dioscorea hispida: Pain syndrome in trigeminal neuralgia, chronic constipation, duodenitis, helminthic infestation, stage I–II hypertensive disease, hypercholesterolemia, parasitic intoxications, biliary dyskinesia of the hypomotor type, recurrent urticaria, atopic dermatitis, acute eczema, furunculosis, irritable bowel syndrome with diarrhea, chronic enteritis, osteoarthritis, dysuric disorders, polycystic ovary syndrome.

Use of Dioscorea hispida in mixtures and complexes: Hyperglycemia in type 2 diabetes mellitus, pancreatitis, hepatosis, bronchial asthma, chronic obstructive bronchitis, chronic prostatitis, allergic rhinitis, gastric ulcer disease, neurodermatitis, follicular keratosis, gallbladder inflammation, grade I–II obesity, premenstrual syndrome.

Pharmacological properties of Dioscorea hispida: analgesic, anthelmintic, hypotensive, antihistamine, antispasmodic, anti-inflammatory, hypocholesterolemic, antibacterial, antifungal, hypoglycemic, immunomodulatory, antiseptic, choleretic, anti-edematous, insecticidal, antiparasitic, antioxidant, hepatoprotective, sedative, nephroprotective, gastroprotective.

Dosage of Pharmaceutical Forms — Dioscorea hispida

Powder — Dioscorea hispida

Indications (Powder): Pain syndrome in trigeminal neuralgia, chronic constipation, duodenitis, helminthic infestation, stage I hypertensive disease, hypercholesterolemia, biliary dyskinesia of the hypomotor type.

Standard Dosage (Powder): 1 gram of powder 2 times a day after meals, with warm water. Duration of intake — up to 21 days.

Enhanced Dosage (Powder): 2 grams of powder 2 times a day in the presence of hypercholesterolemia, pain syndrome in neuropathy, and parasitic intoxication.

Maximum Dosage (Powder): 3 grams of powder 2 times a day is permissible for no more than 5 days for pronounced helminthic infestation or resistant constipation.

Preventive Dosage (Powder): 0.5 grams of powder once a day in the morning for 10 days every two months. Recommended for irritable bowel syndrome, mild hypertension, and elevated cholesterol levels. Suitable for patients over 45 years of age with a body mass index above 25.

Pediatric Dosage (Powder): Permissible for children over 12 years of age with a body weight from 40 kg. Dosage — 0.5 grams once a day, strictly under specialist supervision. The child's gender does not matter.

Contraindications (Powder): Individual intolerance, acute renal failure, exacerbation of gastric ulcer disease. No scientific data on contraindications during pregnancy, lactation, and in children under 12 years have been registered.

Side Effects (Powder): Registered: nausea, headache, temporary increased stool frequency when the dosage exceeds 6 grams per day.

Adjustment for Patient Body Weight (Powder): For body weight less than 60 kg, it is recommended to reduce the dosage by 25%. For body weight more than 90 kg — an increase in dosage by 25% is possible in the absence of contraindications.

Preparation method (Powder): Take 100 grams of dried rhizomes of Dioscorea hispida. Clean from the outer shell, grind into small fragments up to 5 mm. Re-dry at a temperature of 40 degrees Celsius for 12 hours. Grind to a powder using a mill to a dust-like state. Sieve through a sieve with a mesh diameter of 0.5 mm. Package in an airtight glass container.

Storage Conditions and Shelf Life (Powder): Store in a dry, dark place at a temperature of 15 to 25 degrees Celsius, away from electromagnetic sources. Shelf life — 12 months. After opening, use within 45 days.

Dry Extract — Dioscorea hispida

Indications (Dry Extract): Furunculosis, irritable bowel syndrome, chronic enteritis, osteoarthritis, atopic dermatitis, hypercholesterolemia.

Standard Dosage (Dry Extract): 0.3 grams of dry extract 2 times a day during meals, in a course of 10 days.

Enhanced Dosage (Dry Extract): 0.5 grams of dry extract 2 times a day for acute skin inflammation, stool disorders, joint pain, and high plasma lipid concentrations.

Maximum Dosage (Dry Extract): Up to 1 gram 2 times a day for 5 days is possible under medical supervision for severe skin inflammations or for irritable bowel syndrome with exacerbations.

Preventive Dosage (Dry Extract): 0.1 grams once a day in the morning, 20 minutes before meals, for 14 days every 3 months. Recommended for patients with chronic forms of enteritis, the initial stage of hyperlipidemia, overweight patients, and those with dry skin.

Pediatric Dosage (Dry Extract): For children from 14 years of age with a body weight from 45 kg — no more than 0.1 grams once a day. Not recommended for younger children due to the lack of studies.

Contraindications (Dry Extract): Acute stage of ulcerative disease, decompensated hepatic insufficiency. No scientific data on contraindications during pregnancy, lactation, and in children under 14 years have been registered.

Side Effects (Dry Extract): In case of overdose, flatulence, a feeling of heaviness in the epigastrium, and drowsiness are possible.

Adjustment for Patient Body Weight (Dry Extract): For patients with body weight below 60 kg — reduction of dosage by 30%. For weight above 90 kg — an increase in dose by 20% is permissible in the absence of limitations.

Preparation method (Dry Extract): Take 300 grams of ground rhizome of Dioscorea hispida, pour with 2 liters of purified water. Boil over low heat for 60 minutes under a lid. Cool, filter, evaporate in a water bath to 1/3 of the volume. Dry the resulting extract at a temperature not exceeding 50 degrees Celsius to a powder form. Store in dry form.

Storage Conditions and Shelf Life (Dry Extract): Store in airtight containers in a cool place at a temperature of 15–20 degrees Celsius, protected from light. After opening the package, use within 30 days. Shelf life of unopened product — 9 months.

Alcohol-Based Tincture — Dioscorea hispida

Indications (Tincture): Helminthic infestation, stage I hypertensive disease, chronic prostatitis, parasitic intoxications, follicular keratosis.

Standard Dosage (Tincture): 15 drops of tincture 2 times a day before meals, diluted in 50 ml of warm water. Course — up to 14 days.

Enhanced Dosage (Tincture): 25 drops of tincture 2 times a day for pronounced parasitic infestation, chronic prostatitis, or high blood pressure resistant to basic phytotherapy.

Maximum Dosage (Tincture): Up to 30 drops 2 times a day, no more than 5 days in a row, under specialist supervision. Recommended for persistent forms of helminthiasis and follicular keratosis.

Preventive Dosage (Tincture): 10 drops per day in the morning, 30 minutes before meals, for 7 days once every two months. Recommended for chronic parasitic foci in the gastrointestinal tract, mild hypertension, and prevention of seborrheic dermatitis.

Pediatric Dosage (Tincture): Not recommended for children under 16 years due to ethyl alcohol content. Use in adolescence is possible only as prescribed by a doctor in an individually calculated dosage.

Contraindications (Tincture): Liver diseases in the stage of decompensation, chronic alcoholism, epilepsy, organic brain diseases. No data on safety during pregnancy, lactation, and in children under 16 years have been registered.

Side Effects (Tincture): Nausea, dizziness, palpitations in case of overdose. Hypotension is possible in patients with normal or low blood pressure.

Adjustment for Patient Body Weight (Tincture): For patients with body weight below 60 kg — reduction of dosage by 25%. For patients with weight above 90 kg — an addition of 5–10 drops is possible depending on the individual reaction of the body.

Preparation method (Tincture): Grind 100 grams of dry rhizome of Dioscorea hispida. Pour with 500 ml of 70% ethyl alcohol. Infuse in an airtight glass container for 14 days in a dark place at a temperature of 18 to 22 degrees Celsius. Shake daily. After the period, filter the tincture through a fabric filter. Pour into glass bottles with a tight lid.

Storage Conditions and Shelf Life (Tincture): Store in a light-protected place at a temperature of 15 to 25 degrees Celsius. Do not subject to heating or freezing. Shelf life — up to 24 months. After opening, use within 60 days.

Cream — Dioscorea hispida

Indications (Cream): Furunculosis, atopic dermatitis, acute skin inflammation, neurodermatitis, chronic eczema, recurrent urticaria.

Standard Dosage (Cream): Apply a thin layer to affected areas 2 times a day, morning and evening. Course of use — up to 14 days.

Enhanced Dosage (Cream): Up to 3 times a day for pronounced inflammation and itching. Used for neurodermatitis, recurrent urticaria, and weeping forms of dermatitis.

Maximum Dosage (Cream): 4 times a day locally, no more than 5 days in a row on the same area of skin with an area of no more than 15 cm². Suitable for furuncles and localized eczema.

Preventive Dosage (Cream): Once a day in the evening for 7–10 days for dry skin and chronic dermatitis in remission. Recommended for patients with a predisposition to allergic rashes.

Pediatric Dosage (Cream): Use is permissible in children from 5 years. Apply once a day on limited areas (up to 5 cm²). Only under medical supervision.

Contraindications (Cream): Individual intolerance to components, active form of dermatomycosis, open purulent wounds. No scientific data on safety during pregnancy and breastfeeding have been registered.

Side Effects (Cream): Local irritation, hyperemia, burning sensation when applied in increased dosage or on damaged skin.

Adjustment for Patient Body Weight (Cream): Adjustment by body weight is not required, as the cream is applied locally. The area of application is taken into account.

Preparation method (Cream): Take 5 grams of dry extract of Dioscorea hispida, 5 grams of coconut oil, 2 grams of beeswax, 0.5 grams of lecithin, 1 gram of glycerin, 1 gram of lanolin, and 85.5 grams of demineralized water. Melt the coconut oil, wax, and lanolin in a water bath at a temperature of 60 degrees Celsius. Separately, dissolve the extract in water, add glycerin and lecithin. Combine both phases, mix while cooling until a homogeneous texture is formed. Pour into sterile jars.

Storage Conditions and Shelf Life (Cream): Store in tightly closed packaging in the refrigerator at a temperature of 4 to 8 degrees Celsius. Avoid exposure to direct light. Shelf life — 60 days. After opening, use within 15 days.

Cosmetics — Dioscorea hispida

Indications (Cosmetics): Hyperkeratosis, seborrheic dermatitis, hyperpigmentation, age-related skin atrophy, dry skin, chronic eczema, follicular keratosis.

Standard Dosage (Cosmetics): Use of cream, mask, or lotion with a concentration of dry extract of Dioscorea hispida from 0.5% to 2% once a day on cleansed skin. Apply with light massage movements until completely absorbed.

Enhanced Dosage (Cosmetics): Products with a concentration of 3–4% extract should be applied 2 times a day for pronounced pigmentation, age-related atrophy, and hyperkeratosis.

Maximum Dosage (Cosmetics): Products with an extract content of up to 5% are permissible in a course of no more than 10 days for hyperkeratosis and pronounced hyperpigmentation, on limited areas of the skin (face, elbows, knees).

Preventive Dosage (Cosmetics): Use of cream or mask with 0.5% extract 2–3 times a week in the evening. Recommended for women and men from 35 years of age with a tendency to dry skin, the appearance of early wrinkles, and impaired skin barrier.

Pediatric Dosage (Cosmetics): Use in cosmetics for children under 12 years is not recommended. From 12 years, spot application of lotions or creams with an extract concentration of no more than 0.5% is permissible for follicular keratosis and seborrhea.

Contraindications (Cosmetics): Intolerance to formula components, acute forms of dermatosis, weeping eczema. No data on safety during pregnancy and lactation are available.

Side Effects (Cosmetics): In case of overdose and prolonged use, dry skin, peeling, and hyperemia in the application area are possible.

Adjustment for Patient Body Weight (Cosmetics): Not required. Adjustment is made by the area of the lesion and skin sensitivity.

Preparation method (Cosmetics): To create a mask: take 2 grams of dry extract of Dioscorea hispida, 10 grams of white cosmetic clay, 10 grams of aloe vera gel, 5 grams of honey, 3 grams of coconut oil, and 70 grams of water. Mix the clay with the extract and water to a paste consistency. Add aloe gel and honey, mix thoroughly. Introduce coconut oil at a temperature of 35 degrees Celsius. Package in an airtight jar.

Storage Conditions and Shelf Life (Cosmetics): Store in a cool place at a temperature of 4 to 10 degrees Celsius, protected from light. Shelf life — up to 30 days. After opening, use within 7 days. Do not freeze; do not leave at room temperature for more than 2 hours in a row.

Serum — Dioscorea hispida

Indications (Serum): Hyperpigmentation, age-related skin atrophy, dry skin, melasma.

Standard Dosage (Serum): Apply 4–5 drops of serum to cleansed facial skin once a day in the evening.

Enhanced Dosage (Serum): Apply the serum twice a day (morning and evening) for pronounced pigmentation and pronounced dry skin.

Maximum Dosage (Serum): No more than 6 drops twice a day in a course of up to 14 days for persistent melasma or age-related changes.

Preventive Dosage (Serum): 3 drops of serum 2–3 times a week in the evening for 4 weeks in a course every 3 months. Recommended for persons over 35 years with dry skin and a tendency to hyperpigmentation.

Pediatric Dosage (Serum): Use is not recommended for children and adolescents under 16 years due to the concentration of the active extract.

Contraindications (Serum): Intolerance to the component, active eczema or dermatosis. No data on safety during pregnancy and lactation have been registered.

Side Effects (Serum): In case of overdose, redness, itching, and mild burning in the application area are possible.

Adjustment for Patient Body Weight (Serum): Adjustment by weight is not required. Dose management is performed by skin area.

Preparation method (Serum): Combine 5 grams of dry extract of Dioscorea hispida with 20 grams of cold-pressed coconut oil, 10 grams of hyaluronic acid (low molecular weight), 0.5 grams of vitamin E, and 64.5 grams of distilled water. Mix at a temperature of 25–30°C until a homogeneous solution is obtained, then filter and pour into dark glass dropper bottles.

Storage Conditions and Shelf Life (Serum): Store in the refrigerator at 4–8°C, away from light. Use within 45 days. After opening — no more than 30 days.

Mask — Dioscorea hispida

Indications (Mask): Hyperkeratosis, seborrheic dermatitis, dry skin, age-related skin atrophy.

Standard Dosage (Mask): Apply the mask once a week for 15–20 minutes. Cleanse the skin before application.

Enhanced Dosage (Mask): Apply twice a week for pronounced dryness and hyperkeratosis, for up to 20 minutes.

Maximum Dosage (Mask): Apply three times a week for no longer than 15 minutes for 10 days during seasonal exacerbations of seborrheic dermatitis.

Preventive Dosage (Mask): Apply once every two weeks in the evening in a course of 4 weeks. Recommended for dry and sensitive skin in persons over 30 years.

Pediatric Dosage (Mask): Use in children under 12 years is not recommended. From 12 to 16 years — only once and no longer than 10 minutes.

Contraindications (Mask): Acute inflammatory skin diseases, open wounds, allergy to components. No data on safety during pregnancy and lactation.

Side Effects (Mask): In case of overdose, hyperemia, a feeling of tightness, and slight itching after rinsing are possible.

Adjustment for Patient Body Weight (Mask): Adjustment is not required — applied locally, taking into account the skin type and area.

Preparation method (Mask): Mix in a clean container: 3 grams of dry extract of Dioscorea hispida, 15 grams of white cosmetic clay, 10 grams of yogurt, 5 grams of coconut oil, 1 gram of glycerin, and 65 grams of filtered water. Mix to a homogeneous state at 25°C. Distribute into tubes or jars.

Storage Conditions and Shelf Life (Mask): Store in the refrigerator at a temperature of 4–8°C, in a place protected from light. Shelf life — 30 days. After opening, use within 7 days.

Toxicity and Biosafety of Dioscorea hispida

Toxicity studies of the rhizomes of Dioscorea hispida confirm the presence of pronounced dose-dependent toxic action when used in high concentrations. In raw form, the tubers of the plant contain dioscin and other steroid saponins, as well as cyanogenic glycosides (especially dioscorine), which have neurotoxic properties.

In experimental studies on mice, it was established that oral administration of Dioscorea hispida extract at a dose of 1000 mg/kg body weight caused signs of toxicity (diarrhea, hypoactivity, lethargy), but did not lead to death. The LD₅₀ upon a single administration of the alcoholic extract was about 2500 mg/kg for mice, which classifies this plant as subtoxic.

With prolonged use of the extract (for 28 days) at doses up to 200 mg/kg in rats, no significant deviations in clinical and biochemical blood parameters and in the function of the liver and kidneys were detected, which allows us to speak of an acceptable safety profile for therapeutic use after thermal or chemical detoxification of the raw material.

It is important to note that consumption of the raw tuber as food or as an infusion without prior neutralization of toxins can cause severe poisoning with symptoms of CNS depression, convulsions, and in rare cases — death, especially in children.

Reference: https://www.ncbi.nlm.nih.gov/p...

Pharmacodynamics — Dioscorea hispida

The pharmacodynamic properties of Dioscorea hispida are due to the presence of steroid saponins (primarily diosgenin), as well as cyanogenic glycosides and other biologically active compounds that affect various physiological systems. The plant exhibits a modulating effect on the functions of the central and autonomic nervous systems, including sedative and moderate neurotoxic effects when therapeutic doses are exceeded. A decrease in spontaneous motor activity, suppression of conditioned reflexes, and potentiation of effects mediated by γ-aminobutyric acid (GABA) have been noted, indicating a possible effect on GABAergic neurotransmission.

At the level of the gastrointestinal tract, preparations of Dioscorea hispida have local and systemic effects. An antispasmodic effect is noted, realized probably through blockade of calcium channels of smooth muscles and mediated influence on parasympathetic regulatory mechanisms. A choleretic effect and participation in the stimulation of small intestinal motility have been confirmed. Due to the high content of saponins, plant components exhibit the ability to stimulate mucus secretion and protect mucous membranes from irritating factors.

The systemic anti-inflammatory effect of Dioscorea hispida extracts is associated with suppression of the synthesis of pro-inflammatory mediators, such as prostaglandins, through inhibition of cyclooxygenase-2 (COX-2) activity, as well as suppression of interleukin production (IL-1β, IL-6). An antioxidant effect has also been noted, expressed in the ability to bind reactive oxygen species and prevent lipid peroxidation, which contributes to the stabilization of cell membranes.

From the immune system, the drug has moderate immunosuppressive activity, manifested in a decrease in the expression of activated T-lymphocytes and suppression of delayed-type hypersensitivity reactions. This activity may be mediated through inhibition of the transcription factor NF-κB and suppression of the expression of inflammation genes associated with it.

Dermatotropic properties of Dioscorea hispida are due to the effect of saponins and phenolic compounds on skin regeneration processes, keratinocyte proliferation, and collagen synthesis. Local inhibition of tyrosinase, involved in melanin synthesis, is also assumed, which forms the prospect of using the plant as part of whitening and dermoregulating agents.

At the level of the endocrine system, steroid saponins of Dioscorea hispida are considered as possible precursors for the synthesis of steroid-like compounds. In in vitro experiments, the ability of diosgenin to modulate the synthesis of progestogens and androgens has been established, however, the clinical significance of these effects with oral use of the plant remains limited due to the low biotransformation of saponins in humans.

Thus, the pharmacodynamic profile of Dioscorea hispida includes neurotropic, antispasmodic, choleretic, antioxidant, anti-inflammatory, immunomodulatory, and dermatotropic actions, realized through effects on ion channels, inflammatory mediators, enzyme systems, and signaling cascades.

References:
https://www.sciencedirect.com/...
https://www.ncbi.nlm.nih.gov/p...
https://link.springer.com/arti...

Pharmacokinetics — Dioscorea hispida

The pharmacokinetic characteristics of Dioscorea hispida depend on the form of administration, the composition of the raw material, and the degree of pre-treatment, taking into account the presence in the plant of both water-soluble and fat-soluble biologically active compounds. With oral administration of preparations from processed rhizomes, slow absorption of active substances in the gastrointestinal tract is observed, due to partial inactivation of saponins and glycosides under the action of gastric acid and enzymes. However, preliminary thermal and enzymatic treatment (including drying, boiling, alcohol extraction) significantly reduces toxicity and increases the bioavailability of active components.

The absorption of saponins and diosgenin in the intestine is limited and may depend on the state of the microflora, since bacterial transformation is a key stage of their activation. Studies indicate that intestinal bacteria are able to convert dioscin and other saponins into biologically active steroid-like compounds, which then enter the systemic circulation. In this regard, the effectiveness of administration may be individual and depend on the composition of the microbiota.

After absorption, active metabolites are distributed mainly in the liver, skin, kidneys, and mucous membranes. Accumulation in the skin and mucous membranes may explain the effectiveness of external forms. Distribution by organs is characterized by moderate affinity for lipophilic structures, especially in the case of fat-soluble components of plant origin (oil extracts and creams).

Metabolism of active substances of Dioscorea hispida occurs mainly in the liver with the participation of cytochrome P450 enzymes. Hydrolysis of glycosidic compounds and degradation of saponins are accompanied by the formation of less active metabolites, which undergo further conjugation (glucuronidation, sulfation) and are excreted with bile and urine. Partial elimination is possible through the intestine in unchanged form at high doses.

Excretion is carried out primarily by the kidneys and intestines, while fat-soluble components (with transdermal or local use) may remain in the skin for up to 48 hours. Data on the participation of the lungs or skin in the excretion of components in systemic form are absent. When used in the form of creams and cosmetic forms, systemic entry is minimal, and the effect is mainly local.

Thus, the pharmacokinetics of Dioscorea hispida is determined by the low bioavailability of saponins upon oral administration, the need for their metabolic activation by microflora and the liver, as well as predominant excretion with bile and urine. With external use, the action is localized and accompanied by limited systemic effect.

References:
https://www.ncbi.nlm.nih.gov/p...
https://www.sciencedirect.com/...
https://pubmed.ncbi.nlm.nih.go...

Mechanisms of Action and Scientific Rationale — Dioscorea hispida

The pharmacological activity of Dioscorea hispida is due primarily to the presence of steroid saponins (including dioscin and diosgenin), as well as phenolic compounds and cyanogenic glycosides. The main biotargets through which their effect is realized include enzyme systems of the inflammatory cascade, cell receptors, and signaling pathways that regulate inflammation, oxidative stress, and the immune response.

Steroid saponins of Dioscorea hispida inhibit the activity of cyclooxygenase-2 (COX-2) and lipoxygenase (LOX), reducing the production of pro-inflammatory prostaglandins and leukotrienes. These mechanisms have been confirmed in experimental models, where a decrease in the level of PGE2 and LTB4 was observed after treatment of cell cultures with plant extracts. Simultaneously, suppression of NF-κB expression and its translocation to the nucleus is observed, which prevents the transcription of genes encoding pro-inflammatory cytokines, including TNF-α, IL-1β, and IL-6.

At the level of antioxidant defense, extracts of Dioscorea hispida exhibit a pronounced ability to inactivate reactive oxygen species (ROS) and restore glutathione (GSH) levels. This effect is realized through activation of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) enzymes. These antioxidant properties contribute to the protection of cell membranes from lipid peroxidation and the preservation of the structural integrity of tissues.

The immunomodulatory effect of Dioscorea hispida is due to suppression of the production of pro-inflammatory cytokines and a decrease in the expression of T-lymphocyte activation molecules, such as CD69 and CD25. A decrease in MHC II expression on antigen-presenting cells has also been identified, which indicates the ability of the plant extract to modulate the adaptive immune response. These effects are confirmed in vitro on RAW 264.7 macrophages and peripheral blood mononuclear cells.

At the level of neurotropic activity, extracts of Dioscorea hispida demonstrate a moderate modulating effect on GABAergic neurotransmission. Some studies indicate potentiation of GABAA receptor activity, accompanied by sedative and anxiolytic effects. Weak inhibition of acetylcholinesterase (AChE) is also assumed, which may affect cognitive functions, although the clinical significance of these effects requires additional validation.

Dermatotropic activity of Dioscorea hispida is realized through inhibition of tyrosinase, a key enzyme of melanogenesis, which is confirmed by a decrease in melanin synthesis in melanocyte cultures. This allows the use of plant extracts in whitening cosmetics and products for correcting hyperpigmentation.

Plant saponins also exhibit membranotropic properties — they increase the permeability of cell membranes, contributing to increased absorption of hydrophilic substances and ions, which may be useful for modulating absorption in complex therapy. Additionally, inhibition of α-glucosidase and α-amylase has been registered, which indicates a possible effect on carbohydrate metabolism.

Thus, the mechanisms of action of Dioscorea hispida cover multicomponent regulation of inflammatory, oxidative, immune, and neurotransmitter processes, which explains the variety of pharmacological effects with systemic and local use.

References:
https://www.ncbi.nlm.nih.gov/p...
https://link.springer.com/arti...
https://www.sciencedirect.com/...
https://pubchem.ncbi.nlm.nih.g...

Synergy — Dioscorea hispida

Scientific publications confirm the presence of synergistic interaction between extracts of Dioscorea hispida and plant components with similar or complementary pharmacological activity. One of the most studied areas of synergy is the potentiation of anti-inflammatory and antioxidant effects when combining Dioscorea hispida with flavonoid-containing plants, such as Curcuma longa and Camellia sinensis. In in vitro studies, it has been established that the combined effect of saponins of Dioscorea hispida and curcumin leads to enhanced suppression of NF-κB activation and a more pronounced decrease in IL-6 and TNF-α production compared to monotherapy with each component.

Synergistic interaction between Dioscorea hispida and Withania somnifera has also been identified with respect to the regulation of GABAergic activity and anxiolytic potential. Combined use of aqueous extracts of both plants demonstrated a potentiating effect on GABRA1 expression and a reduction in behavioral signs of anxiety in model organisms. The synergy mechanism is presumably associated with parallel modulation of GABAA receptor subtypes and suppression of AChE activity.

Systemic modulating interaction of Dioscorea hispida with Panax ginseng has been confirmed within the framework of metabolic models. Additive inhibitory action on α-glucosidase activity was found, as well as enhanced antioxidant protection, expressed in an increase in GSH levels and SOD activity. These data indicate a functional complementation of the action of saponins contained in both taxa and the possibility of an enhanced effect with simultaneous use.

Synergy with local use has been recorded when combining Dioscorea hispida with Centella asiatica. In combined cosmetic formulations, such a combination enhances the stimulation of collagen synthesis, increases fibroblast proliferation, and accelerates the healing of skin damage. The proposed mechanism includes combined activation of the TGF-β/Smad signaling pathway and suppression of matrix metalloproteinase activity (MMP-1 and MMP-9).

Thus, Dioscorea hispida demonstrates predominantly potentiating and additive types of synergy with plants possessing anti-inflammatory, antioxidant, sedative, and dermatotropic activity. Combined use enhances the effect on the same cellular targets and enzyme systems, and also expands the spectrum of action.

References:
https://www.sciencedirect.com/...
https://pubmed.ncbi.nlm.nih.go...
https://link.springer.com/arti...
https://www.ncbi.nlm.nih.gov/p...

Geography of Use and Traditional Medicine — Dioscorea hispida

Dioscorea hispida is traditionally used in the folk medicine of Southeast Asia, including Indonesia, Malaysia, the Philippines, Thailand, Vietnam, and the southern regions of China. The plant is most actively used on the islands of Java, Sumatra, and Kalimantan, where it is part of the ethnobotanical practices of the Malay, Sundanese, Javanese, and Batak ethnic groups. Local residents have long used rhizomes and tubers after special processing — as a rule, repeated soaking, to remove natural toxins, including dioscorine.

In traditional Indonesian and Philippine medicine, the plant was used in the form of boiled and dried tubers, which were then ground into a paste or powder. These forms were used for wraps, poultices, and ointments. In the culture of the Dayaks of Borneo, Dioscorea hispida tubers were also used externally in the form of warm cakes applied to the body in special purification ceremonies aimed at expelling the "spirit of disease." In some tribal cultures of Malaysia and the Philippines, the plant was considered a plant of "dual action": potentially dangerous with inept use and extremely valuable after ritual purification.

In the Thai tradition, Dioscorea hispida is known as "มันทรงกระเทียม" and is used mainly in the northern provinces, such as Chiang Mai, Lampang, and Phrae. There, the plant is used as part of external remedies, which, according to local beliefs, contribute to the purification of the body from "hot" energies. In Thai ethnomedicine, the use of Dioscorea hispida in steam baths and herbal compresses used after childbirth or during recovery of strength has also been recorded.

In the cultures of Southeast Asia, Dioscorea hispida rhizomes were often used in ritual practice as a cleansing agent. There is evidence of the use of the plant in exorcism rituals, including fumigation of premises with powder of the dried tuber. In Bali and South Sulawesi, the plant was used by shamans (balians) as part of multicomponent ritual collections for purifying dwellings, especially after death, illness, or conflicts.

Written mentions of Dioscorea hispida are found in Malay medicinal treatises of the 17th–19th centuries, where the plant is described as "poisonous but cleansing." In local herbals, long-term fermentation or boiling of the tubers for several days was recommended, which, according to healers, "expelled the evil principle." The plant is also found in colonial botanical descriptions of British and Dutch doctors, who recorded both cases of poisoning and traditional use for medicinal purposes.